Pricing Log in Create free account

Anika Therapeutics Inc. (ANIK) vs BioAge Labs, Inc. (BIOA)

Anika Therapeutics Inc. and BioAge Labs, Inc. are both Drug Manufacturers Specialty & Generic companies. Anika Therapeutics Inc. and BioAge Labs, Inc. are of similar size ($258.7M and $254.3M). Anika Therapeutics Inc. has the higher net margin (−3.14% vs −1,253.6%) and the higher return on invested capital (−3.24% vs −21.8%). Across the 16 metrics below, Anika Therapeutics Inc. leads on 10 and BioAge Labs, Inc. on 6.

Valuation

Metric ANIK BIOA Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 2.13 29.58 2.08
P/B 1.88 0.73 1.79
Price to free cash flow 458.01 n/m 16.29
EV/EBITDA 476.54 0.52 12.22
EV/Sales 2.02 (7.23) 2.87
Earnings yield (1.35%) (46.03%) (15.94%)
Free cash flow yield 0.22% (101.34%) 0.00%

Profitability

Metric ANIK BIOA Drug Manufacturers Specialty & Generic median
Gross margin 62.16% 100.00% 53.51%
Operating margin (4.24%) (1,401.81%) 0.00%
Net margin (3.14%) (1,253.60%) (2.45%)
Free cash flow margin 0.47% (2,997.41%) 0.00%
Return on equity (2.66%) (34.56%) (0.80%)
Return on assets (2.04%) (32.05%) (1.67%)
Return on invested capital (3.24%) (21.75%) 0.00%

Growth

Metric ANIK BIOA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 5.33% — 5.22%
EPS growth (last fiscal year) 80.16% 66.21% 42.91%
Revenue growth, 5-year CAGR (2.86%) — 7.24%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ANIK BIOA Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.04
Current ratio 4.48 15.51 2.41
Net debt to EBITDA 10.80 3.01 1.01

Dividend

Metric ANIK BIOA Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric ANIK BIOA Drug Manufacturers Specialty & Generic median
Market cap 258.69m 254.27m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack